Who should avoid GHK-CU Wilson's disease or copper metabolism disorders Active malignancies (until more research exists) Pregnancy and breastfeeding Known copper sensitivity or allergy Those unable to maintain sterile injection technique When uncertain, consult a healthcare provider familiar with peptide research
BPC-157 remains investigational by comparison, with animal data suggesting potential but no controlled human trials confirming cardiovascular benefits
These properties make it particularly valuable in studies focused on adipose tissue modulation and metabolic efficiency research
Vitamin B12 Methylcobalamin 1500mcg Injection | 5 x 2ml | IM / IV Use 71.98 Original price was: 71.98.45.00Current price is: 45.00
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose